Press release

Lash Group and Medisafe Form Strategic Collaboration to Advance Patient Adherence by Deploying Mobile Engagement Before the First Fill

0
Sponsored by Businesswire

Lash Group, a patient support services company and a part of
AmerisourceBergen, and Medisafe, a leading medication management
platform, today announced that, together, they will provide an
end-to-end patient adherence solution that combines a top-rated mobile
platform within Lash Group’s current hub services programs.

The Medisafe mobile application provides real-time, personalized
interventions using predictive analytics and machine learning, and now
through this innovative collaboration, Medisafe will identify “at-risk”
patients for Lash Group’s licensed clinicians. This patient journey
solution now provides support after therapy is prescribed, but before
the first fill. The collaboration also creates visibility into the
patient’s approval and shipment status of their medication, while
simultaneously providing the opportunity to educate and engage with
patients.

“We know that nearly three in four patients are non-adherent to their
medication in some way,” said Tommy Bramley, Ph.D., President of Lash
Group. “At Lash Group, we are always building on our legacy of helping
patients with access, affordability, and adherence to optimize outcomes.
We are excited to work with Medisafe to provide an additional layer of
digital communication to improve adherence rates and instill healthy
behaviors. We meet patient needs by providing both digital and human
support to help guide patients on their path to recovery and to a higher
quality of life.”

According to the Annals of Internal Medicine, more than 30 percent of
initial prescriptions are never filled. And even the 70 percent of
patients who do fill a prescription often fall off therapy in the first
few months. Medisafe’s research shows that refill rates for its users
are as much as 17 percent higher than for non-users.

Specialty medications often require a rigorous health benefit
verification and approval process, resulting in long lag times before
patients receive their initial supply. Providing patients with
transparency into the process and setting expectations on delivery
timelines, while assisting with potential copay support program
enrollment, can help temper disengagement.

“We are excited to move upstream in the patient journey making it easier
for new patients to get started on therapy. And this solution offers
patients further support throughout their journey as a trained clinician
is never more than a tap away,” said Omri Shor, CEO of Medisafe. “Our
strategic collaboration will improve the well-being of patients with
severe illness and complex medication regimens at scale by helping them
stay adherent to specialty medications for longer. We see great value
working with Lash Group to offer this high-tech, high-touch approach.”

About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving
services and business solutions that improve access to care. Tens of
thousands of healthcare providers, veterinary practices and livestock
producers trust us as their partner in the pharmaceutical supply chain.
Global manufacturers depend on us for services that drive commercial
success for their products. Through our daily work—and powered by our
21,000 associates—we are united in our responsibility to create
healthier futures. AmerisourceBergen is ranked #12 on the Fortune 500,
with more than $160 billion in annual revenue. The company is
headquartered in Valley Forge, Pa. and has a presence in 50+ countries.
Learn more at amerisourcebergen.com.

About Medisafe

Medisafe is the personalized medication management platform addressing
non-adherence across a care journey, a $300 billion problem in the US
alone. Medisafe’s cloud-based mobile platform personalizes content,
resources and interventions — such as educational videos, coupons and
motivational messages — based on each user’s regimen, condition and
specific circumstance. Medisafe fosters collaboration among patients,
their loved ones and healthcare professionals through caregiver tools
and reports, and helps the healthcare professionals improve health
outcomes and sustain quality care initiatives. Medisafe’s almost five
million registered patient and caregiver users have recorded over one
billion successful medication doses on their iOS and Android smartphones
and tablets and contributed 200,000 user reviews that average 4.7 out of
5 stars in the App Store and Google Play app stores. Medisafe is a HIPAA and GDPR compliant
solution and ISO
27001:2013
 certified.